in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..

.. a little under 60% of these encounters resulted in hospitalization and of these, about 13% required intensive care.. august 2010  (16).